Computed Tomography Enterography Detects Intestinal Wall Changes and Effects of Treatment in Patients With Crohn's Disease

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 8, 2011, Pages

  Bruining, David H ^a   Loftus, Edward V ^a   Ehman, Eric C ^a   Siddiki, Hassan A ^a   Nguyen, Douglas L ^a   Fidler, Jeff L ^a   Huprich, James E ^a   Mandrekar, Jayawant N ^a   Harmsen, William S ^a   Sandborn, William J ^a   Fletcher, Joel G ^a  

^a MAYO CLINIC   (United States)

Author keywords

IBD; Imaging; Inflammatory Bowel Disease; Intestinal Wall Changes

Indexed keywords

AZATHIOPRINE; BIOLOGICAL MARKER; BUDESONIDE; C REACTIVE PROTEIN; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; PREDNISONE;

ABDOMINAL MASS; ABDOMINAL PAIN; ADULT; ARTICLE; COMPUTED TOMOGRAPHY ENTEROGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DISEASE ACTIVITY; FEMALE; FEVER; HUMAN; IMAGE ENHANCEMENT; INTESTINE WALL; MAJOR CLINICAL STUDY; MALE; RADIOLOGICAL PARAMETERS; RETROSPECTIVE STUDY; SYMPTOMATOLOGY; TREATMENT RESPONSE;

EID: 79960554386     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.04.025     Document Type: Article

References (21)

1. Cosnes J., Cattan S., Blain A., et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002, 8:244-250.
2. D'Haens G.R., Fedorak R., Lémann M., et al. Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease. Inflamm Bowel Dis 2009, 15:1599-1604.
3. Frøslie K.F., Jahnsen J., Moum B.A., et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007, 133:412-422.
4. Rutgeerts P., Feagan B.G., Lichtenstein G.R., et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology 2004, 126:402-413.
5. Sandborn W.J. How to avoid treating irritable bowel syndrome with biologic therapy for inflammatory bowel disease. Dig Dis 2009, (27 Suppl 1):80-84.
6. Freeman H.J. Limitations in assessment of mucosal healing in inflammatory bowel disease. World J Gastroenterol 2010, 16:15-20.
7. Terheggen G., Lanyi B., Schanz S., et al. Safety, feasibility, and tolerability of ileocolonoscopy in inflammatory bowel disease. Endoscopy 2008, 40:656-663.
8. Booya F., Fletcher J.G., Huprich J.E., et al. Active Crohn disease: CT findings and interobserver agreement for enteric phase CT enterography. Radiology 2006, 241:787-795.
9. Solem C.A., Loftus E.V., Fletcher J.G., et al. Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc 2008, 68:255-266.
10. Siddiki H.A., Fidler J.L., Fletcher J.G., et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR Am J Roentgenol 2009, 193:113-121.
11. Higgins P.D., Caoili E., Zimmermann M., et al. Computed tomographic enterography adds information to clinical management in small bowel Crohn's disease. Inflamm Bowel Dis 2007, 13:262-268.
12. Bruining D.H., Siddiki H., Fletcher J.G., et al. Clinical benefit of CT enterography in suspected or established Crohn's disease: impact on patient management and physician level of confidence. Gastroenterology 2008, 134(Suppl 1):S1211.
13. Hara A.K., Alam S., Heigh R.I., et al. Using CT enterography to monitor Crohn's disease activity: a preliminary study. AJR Am J Roentgenol 2008, 190:1512-1516.
14. Siddiki H., Fletcher J.G., Hara A.K., et al. Validation of a lower radiation computed tomography enterography imaging protocol to detect Crohn's disease in the small bowel. Inflamm Bowel Dis 2011, 17:778-786.
15. Schindera S.T., Nelson R.C., DeLong D.M., et al. Multi-detector row CT of the small bowel: peak enhancement temporal window--initial experience. Radiology 2007, 243:438-444.
16. Bodily K.D., Fletcher J.G., Solem C.A., et al. Crohn disease: mural attenuation and thickness at contrast-enhanced CT enterography--correlation with endoscopic and histologic findings of inflammation. Radiology 2006, 238:505-516.
17. Freeman H.J. Use of the Crohn's disease activity index in clinical trials of biological agents. World J Gastroenterol 2008, 14:4127-4130.
18. Colombel J.F., Solem C.A., Sandborn W.J., et al. Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut 2006, 55:1561-1567.
19. Solem C.A., Loftus E.V., Tremaine W.J., et al. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:707-712.
20. Vandenbroucke F., Mortelé K.J., Tatli S., et al. Noninvasive multidetector computed tomography enterography in patients with small-bowel Crohn's disease: is a 40-second delay better than 70 seconds?. Acta Radiol 2007, 1-9.
21. Young B.M., Fletcher J.G., Booya F., et al. Head-to-head comparison of oral contrast agents for cross-sectional enterography: small bowel distention, timing, and side effects. J Cat 2008, 32:32-38.